Key result
Adolescent patients with PCOS showed no significant difference in serum NT-proBNP levels compared to healthy controls (0.62 vs 1.12 ng/mL, p=0.154), despite having significantly higher insulin levels.
Cross-Sectional (n=50)
In adolescents with PCOS, cardiovascular risk markers such as NT-proBNP and CRP are not elevated despite the presence of significant insulin resistance.
Answers are grounded in this paper and cite their sources.
No NT-proBNP elevation in adolescent PCOS despite insulin resistance; hypothesis-generating and should not yet change clinical monitoring.
OBJECTIVE: Our primary aim was to investigate whether N-terminal pro-brain natriuretic peptide (NT-proBNP) increases in adolescent with polycystic ovary syndrome (PCOS) compared with healthy controls and secondary aim was to determine whether metabolic and hormonal differences exist between groups. METHODS: In this cross-sectional study, 25 adolescent patients with PCOS and 25 normal ovulatory control not suffering from PCOS were involved in the study. Fasting serum NT-proBNP, C-reactive protein (CRP), homocystein, insulin levels and biochemical and hormonal parameters were measured. RESULTS: Serum NT-proBNP was not significantly different in PCOS subjects (0.62 ± 0.80 vs 1.12 ± 1.51 ng/mL, p = 0.154). The mean serum fasting insulin levels (22.64 ± 10.51 vs 13.32 ± 3.97 mIU/mL, p = 0.001) and Homeostasis Model Assessment Insulin-Resistance Index (HOMA-IR) levels (5.16 ± 1.81 vs 2.97 ± 0.89, p = 0.001) were significantly high in the study group. The median serum CRP levels were not significantly different between groups (1 [1-12] vs 1 [1-19] g/dL, p = 0.286). CONCLUSIONS: The present study demonstrated that the levels of BNP, CRP and homocystein were not different in PCOS subjects. Serum insulin levels and HOMA-IR were significantly higher in PCOS subjects. Possible serum markers for PCOS-related metabolic abnormalities and cardiovascular events, may not present in the adolescent years.
No takes yet. Share an insight, caveat, or question.
Deveer et al. (2012) conducted a cross-sectional in Polycystic ovary syndrome (PCOS) (n=50). Polycystic ovary syndrome (PCOS) vs. Normal ovulatory controls was evaluated on Serum NT-proBNP levels (ng/mL) (p=0.154). Adolescent patients with PCOS showed no significant difference in serum NT-proBNP levels compared to healthy controls (0.62 vs 1.12 ng/mL, p=0.154), despite having significantly higher insulin levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: